Professor Emeritus of Obstetrics and Gynecology, Indiana University
Obstetrics & Gynecology
Dr. Frederick B. Stehman, MD
|
|
Give Review
Doctor Frederick B. Stehman, MD practices Obstetrics & Gynecology. He attended University of Kansas School of Medicine. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Indianapolis Monthly" and "Fellow (FACOG)". Frederick B. Stehman is also published. He has 101 publications published. The lastest publication: "Gynecologic cancers metastatic to the breast.' Frederick B. Stehman, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian Cancer.
- Cytokine use and survival in the first-line treatment of ovarian Cancer: A Gynecologic Oncology Group Study.
- State of the Science in Ovarian Cancer Quality of Life Research: A Systematic Review.
- Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian Cancer.
- Outcome of stage IVA Cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
- Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical Carcinoma: a Gynecologic Oncology Group study.
- A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.
- Impact of hydronephrosis on outcome of stage IIIB Cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gy...
- Mortality rates due to gynecologic Cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
- Node count and groin recurrence in early vulvar Cancer: A Gynecologic Oncology Group study.
- Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical Carcinoma: follow-up of a Gynecologic Oncology Group trial.
- Carcinoma of the vulva.
- A thousand several tongues.
- Innovations in the treatment of invasive Cervical cancer.
- Stage Ia-IIa Cancer of the cervix.
- "What's in a name? That which we call a rose, by any other name.".
- Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian Cancer treated with fertility-sparing therapy.
- 2004 consensus statements on the management of ovarian Cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conferenc...
- 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.
- Clinical trials in ovarian Carcinoma: requirements for standard approaches and regimens.
- Intraoperative radiotherapy in advanced or recurrent gynecologic Cancer.
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group.
- Concurrent chemotherapy and radiation therapy in primary Cancer of the cervix.
- The abandoned radical hysterectomy: a Gynecologic Oncology Group Study.
- The significance of thrombocytosis in patients with locally advanced cervical Carcinoma: a Gynecologic Oncology Group study.
- Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical Carcinoma.
- Gynecologic Cancers metastatic to the breast.
- A prospective controlled trial of early postoperative oral intake following major abdominal gynecologic surgery.
- Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical Carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
- What is the appropriate management of early stage Cervical cancer (International Federation of Gynecology and Obstetrics stages I and IIA), surgical assessment of lymp...
- Is more always better?
- Sites of failure and times to failure in Carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study.
- Carcinoma of the cervix treated with chemotherapy and radiation therapy. Cooperative studies in the Gynecologic Oncology Group.
- Hydroxyurea versus misonidazole with radiation in cervical Carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
- Blood transfusion and the risk of recurrence in squamous Carcinoma of the vulva.
- Prognostic factors in locally advanced Carcinoma of the cervix treated with radiation therapy.
- Early invasive disease: risk assessment and management.
- Cancers of the uterine cervix and endometrium: major issues and future research directions.
- Radiation to the intact groin.
- Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gynecologic Oncology Group.
- Proliferative and cytotoxic responses of Human cord blood T lymphocytes following allogeneic stimulation.
- Evaluation and comparison of histopathologic grading systems of epithelial Carcinoma of the uterine cervix: Gynecologic Oncology Group studies.
- Quality assessment and assurance programs in the Gynecologic Oncology Group.
- The fate of the ovaries after radical hysterectomy and Ovarian transposition.
- Comparison of hematopoietic progenitor cells in Human umbilical cord blood collected from neonatal infants who are small and appropriate for gestational age.
- The management of ovarian Carcinoma.
- Bowenoid dysplasia of the vulva.
- Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenoCarcinoma: a Gynecologic Oncology Group Study.
- Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.
- A phase II study of PALA (NSC 224131) in patients with advanced ovarian Carcinoma. A Gynecologic Oncology Group study.
- A clinical evaluation of chlorhexidine gluconate spray as compared with iodophor scrub for preoperative skin preparation.
- Secondary Ovarian neoplasia. A clinicopathologic study of 35 cases.
- Treatment of advanced epithelial ovarian Cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
- PALA (NSC-224131) in advanced Carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group.
- Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical Carcinoma. A Gynecologic Oncology Group study.
- Failure of hexamethylmelamine as salvage therapy in ovarian epithelial adenoCarcinoma resistant to combination chemotherapy.
- Epithelioid sarcoma of the vulva. Evidence suggesting a more aggressive behavior than extra-genital epithelioid sarcoma.
- Assessment of primary gynecologic malignancies: comparison of 0.15-T resistive MRI with CT.
- Peritoneo-cystic shunt for malignant ascites.
- Verrucous Carcinoma of the vulva.
- Second-look laparotomy after chemotherapy in the management of Ovarian malignancy.
- Lymphangiosarcoma of the edematous thigh after radiation therapy for Carcinoma of the vulva.
- Intraoperative radiotherapy in advanced, recurrent or metastatic malignancy.
- Randomized trial of three cisplatin dose schedules in squamous-cell Carcinoma of the cervix: a Gynecologic Oncology Group study.
- Estrogen and progesterone receptors in Uterine sarcomas.
- Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell Carcinoma of the cervix: a Gynecologic Oncology Group Study.
- AdenoCarcinoma corpus et colli: analysis of diagnostic variables.
- Biopsy of the scalene fat pad in Carcinoma of the cervix uteri metastatic to the periaortic lymph nodes.
- Pitfalls in interpretation of computed tomography prior to second-look laparotomy in patients with ovarian Cancer.
- Ovarian Carcinoma: adjuvant treatment with P-32.
- Malignant papillary lesions of the endometrium.
- Primary Carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy.
- A phase II study of carboplatin in advanced squamous cell Carcinoma of the cervix (a Gynecologic Oncology Group Study).
- The role of fine needle aspiration cytology in the management of gynecologic malignancies.
- The importance of peritoneal cytology in endometrial Carcinoma.
- A comparison of findings at second-look laparotomy with preoperative computed tomography in patients with ovarian Cancer.
- A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in Carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
- The sonographic appearance of the irradiated breast.
- Osteosarcoma of the Uterine cervix associated with hyperplastic and atypical mesonephric rests.
- Poorly differentiated (small cell) Carcinoma of the ovary in young women: evidence supporting a germ cell origin.
- Steroid receptors and clinical outcome in patients with adenoCarcinoma of the endometrium.
- Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian Carcinoma.
- Eaton-Lambert syndrome as a harbinger of recurrent small-cell Carcinoma of the cervix with improvement after combination chemotherapy.
- Human papillomavirus deoxyribonucleic acid in lesions of the female genital tract: evidence for type 6/11 in squamous Carcinoma of the vulva.
- Features associated with survival and disease-free survival in early endometrial Cancer.
- A phase II evaluation of mitolactol in patients with advanced squamous cell Carcinoma of the cervix: a Gynecologic Oncology Group Study.
- A prospective surgical pathological study of stage I squamous Carcinoma of the cervix: a Gynecologic Oncology Group Study.
- Cisplatin, vinblastine, and bleomycin as second-trial therapy in ovarian Carcinoma. A pilot study of the Gynecologic Oncology Group.
- DNA content as a prognostic index in gestational trophoblastic neoplasia.
- Human immunodeficiency virus testing in patients with invasive cervical Carcinoma: a prospective trial of the gynecologic oncology group.
- Experimental basis of cord blood transplantation.
- Teniposide (VM-26) in patients with non-squamous-cell Carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
- Trends in the operative management of invasive squamous Carcinoma of the vulva at Indiana University, 1974 to 1988.
- Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group.
- Experience with hydroxyurea as a radiosensitizer in Carcinoma of the cervix.
- Early stage I Carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gyne...
- Groin dissection versus groin radiation in Carcinoma of the vulva: a Gynecologic Oncology Group study.
- Concurrent chemoradiation in Carcinoma of the uterine cervix.
- Recurrent squamous Carcinoma of the vulva.
- Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian Carcinomas.
Schools
University Of Michigan Medical School
University Kans Med Center
UCLA Med Center
Procedures Preformed
- Colporrhaphy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Indianapolis Monthly
- Fellow (FACOG)
Education
-
University of Kansas School of Medicine -
University of Michigan Medical School
Drug Facts
| NPI NUMBER | 1356377899 | |
| NPPES Provider LastName | STEHMAN | |
| NPPES Provider FirstName | FREDERICK | |
| NPPES Provider ZIPCode | 462025149 | |
| NPPES Provider State | IN | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 70.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 15.71 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356377899 |
| Last Name Of The Provider | STEHMAN |
| First Name Of The Provider | FREDERICK |
| View All |
Similar Doctors
|
|
Dr. Michael J. Callahan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olive M. Soriero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory P. Sutton, MD |
|
Dr. David H. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hans E. Geisler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Giuseppe Delpriore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan A. Fisch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lyree N. Mikhail, MD
This Doctor is OpenDoctor Recommended.
|